Predictors for and coverage of influenza vaccination among HIV ‐positive patients: a cross‐sectional survey
ConclusionsA low influenza vaccination rate of 11.9% was detected in this HIV‐positive cohort. The most effective impact for a positive vaccination status was direct recommendation of the influenza vaccine by the attending physician. (Source: HIV Medicine)
Source: HIV Medicine - December 30, 2016 Category: Infectious Diseases Authors: N Harrison, W Poeppl, H Herkner, KD Tillhof, K Grabmeier ‐Pfistershammer, A Rieger, C Forstner, H Burgmann, H Lagler Tags: Original Research Source Type: research
Impact of immigration on HIV mother ‐to‐child transmission in Western Europe
(Source: HIV Medicine)
Source: HIV Medicine - December 29, 2016 Category: Infectious Diseases Authors: A Soriano ‐Arandes, A Noguera‐Julian, C Fortuny, Tags: Letter to the Editor Source Type: research
Accuracy of self ‐report of HIV viral load among people with HIV on antiretroviral treatment
ConclusionsThere is a high level of accuracy of a self‐report of undetectable VL in people on ART in the UK. Overall, accurate knowledge of personal VL level varied according to demographic, socioeconomic, HIV‐related and health‐related factors. Active identification of people who may benefit from increased levels of support and engagement in care is important. (Source: HIV Medicine)
Source: HIV Medicine - December 22, 2016 Category: Infectious Diseases Authors: J Sewell, M Daskalopoulou, F Nakagawa, FC Lampe, S Edwards, N Perry, E Wilkins, R O'Connell, M Jones, S Collins, A Speakman, AN Phillips, AJ Rodger, Tags: Original Research Source Type: research
Rate, correlates and outcomes of repeat pregnancy in HIV ‐infected women
ConclusionsYounger and foreign women were more likely to have a repeat pregnancy; in women with sequential pregnancies, the second pregnancy was characterized by a significant improvement in several outcomes, suggesting that women with HIV infection who desire multiple children may proceed safely and confidently with subsequent pregnancies. (Source: HIV Medicine)
Source: HIV Medicine - December 21, 2016 Category: Infectious Diseases Authors: M Floridia, E Tamburrini, G Masuelli, P Martinelli, A Spinillo, G Liuzzi, A Vimercati, S Alberico, A Maccabruni, C Pinnetti, V Frisina, S Dalzero, M Ravizza, Tags: Short Communication Source Type: research
A feasibility study for a clinical decision support system prompting HIV testing
ConclusionsUsing a CPOE‐based clinical decision support application to prompt HIV testing appears both feasible and acceptable to HCWs. Refining the application to provide more accurate risk stratification is likely to make it more effective. (Source: HIV Medicine)
Source: HIV Medicine - December 20, 2016 Category: Infectious Diseases Authors: DR Chadwick, C Hall, C Rae, Ml Rayment, M Branch, J Littlewood, A Sullivan Tags: Short Communication Source Type: research
An oral formulation of efavirenz ‐loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile
ConclusionsCompared with free EFV, lacto‐EFV‐nano is a promising oral nanoformulation with enhanced bioavailability and efficacy of EFV and improved safety. (Source: HIV Medicine)
Source: HIV Medicine - December 20, 2016 Category: Infectious Diseases Authors: P Kumar, YS Lakshmi, AK Kondapi Tags: Original Research Source Type: research
Opt ‐out screening strategy for HIV infection among patients attending emergency departments: systematic review and meta‐analysis
ConclusionsIn this meta‐analysis, the testing uptake of the opt‐out strategy was not different from that of the opt‐in strategy to detect new cases of HIV infection in EDs. (Source: HIV Medicine)
Source: HIV Medicine - December 20, 2016 Category: Infectious Diseases Authors: C Henriquez ‐Camacho, P Villafuerte‐Gutierrez, JA Pérez‐Molina, J Losa, E Gotuzzo, N Cheyne Tags: Original Research Source Type: research
MicroRNA ‐155 is a biomarker of T‐cell activation and immune dysfunction in HIV‐1‐infected patients
ConclusionsOur findings suggest that miR‐155 levels in the peripheral blood of HIV‐1‐infected patients are increased and associated with T‐cell activation. Therefore, miR‐155 is a potential biomarker of the immune response following HIV‐1 infection. (Source: HIV Medicine)
Source: HIV Medicine - December 16, 2016 Category: Infectious Diseases Authors: C Jin, L Cheng, S H öxtermann, T Xie, X Lu, H Wu, A Skaletz‐Rorowski, NH Brockmeyer, N Wu Tags: Original Research Source Type: research
Off ‐licence use of once‐daily maraviroc in children and adolescents with perinatally acquired HIV‐1 infection
(Source: HIV Medicine)
Source: HIV Medicine - December 15, 2016 Category: Infectious Diseases Authors: T Fraser ‐Taliente, NE Mackie, S Kaye, M Nyirenda, C Foster Tags: Letter to the Editor Source Type: research
Screening for intimate partner violence in a London HIV clinic: characteristics of those screening positive
(Source: HIV Medicine)
Source: HIV Medicine - November 30, 2016 Category: Infectious Diseases Authors: S Madge, C Smith, C Warren ‐Gash, J Bayly, A Bartley Tags: Letter to the Editor Source Type: research
aSKINg advice ‐the need for specialist dermatologists in HIV units
(Source: HIV Medicine)
Source: HIV Medicine - November 30, 2016 Category: Infectious Diseases Authors: M Noy, EE Merika, N Morar, M Nelson, LC Fuller Tags: Letter to the Editor Source Type: research
Table of Contents
(Source: HIV Medicine)
Source: HIV Medicine - November 30, 2016 Category: Infectious Diseases Tags: Issue Information Source Type: research
Editorial Board
(Source: HIV Medicine)
Source: HIV Medicine - November 30, 2016 Category: Infectious Diseases Tags: Issue Information Source Type: research
High frequency of potential interactions between direct ‐acting antivirals and concomitant therapy in HIV/hepatitis C virus‐coinfected patients in clinical practice
ConclusionsDrug−drug interactions between DAAs and ART or other commonly prescribed medications are frequently found among HIV/HCV‐coinfected patients. Potential major and minor DDIs are more frequent with 3D, 2D and SMV plus SOF regimens. (Source: HIV Medicine)
Source: HIV Medicine - October 31, 2016 Category: Infectious Diseases Authors: J Mac ías, P Monge, M Mancebo, N Merchante, K Neukam, LM Real, JA Pineda Tags: Original Research Source Type: research
Pregnancies in older women living with HIV in the UK and Ireland
ConclusionsThere has been a significant increase over time in the proportion of deliveries to women living with HIV aged ≥ 40 years, which has implications for pregnancy management, given their increased risk of multiple births, stillbirth and chromosomal anomalies, as also apparent in the general population. (Source: HIV Medicine)
Source: HIV Medicine - October 31, 2016 Category: Infectious Diseases Authors: CL Townsend, A Ruiter, H Peters, C Nelson ‐Piercy, P Tookey, C Thorne Tags: Short Communication Source Type: research
